Haymaker Daily

Has this China Syndrome finally ended?

Feb 25, 2026

∙ Paid

Hello, Subscribers:

One S&P 500 sector that is heavily populated with underpriced stocks is healthcare and, specifically, the sub-sector of pharmaceuticals. The most extreme example of that is Pfizer (PFE), trading at 9 times earnings. Even Merck (MRK), maker of the world’s largest selling drug, Keytruda, trades at a lowly P/E of 13, excluding one-time charges. (Keytruda does lose patent protection in 2028.)

Continue reading this post for free, courtesy of Haymaker.

Or purchase a paid subscription.